Pharmacoeconomic study of chronic constipation in a secondary care centre

Irish Journal of Medical Science

Volumn 184, Issue 4, 2015, Pages 863-870

  Walsh, C ^a   Murphy, J ^a   Quigley, E M M ^b,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Budget impact analysis; Chronic constipation; Laxatives; NICE; Prucalopride

Indexed keywords

LAXATIVE; PRUCALOPRIDE; BENZOFURAN DERIVATIVE;

ARTICLE; BUDGET; CHRONIC CONSTIPATION; CLINICAL ARTICLE; COST CONTROL; DRUG COST; FEMALE; HEALTH CARE; HEALTH CARE COST; HUMAN; MEDICAL AUDIT; SECONDARY HEALTH CARE; ADULT; CHRONIC DISEASE; CONSTIPATION; ECONOMICS; PHARMACOECONOMICS; RETROSPECTIVE STUDY; SECONDARY CARE CENTER;

ADULT; BENZOFURANS; CHRONIC DISEASE; CONSTIPATION; COST SAVINGS; ECONOMICS, PHARMACEUTICAL; FEMALE; HUMANS; LAXATIVES; RETROSPECTIVE STUDIES; SECONDARY CARE CENTERS;

EID: 84945472651     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-014-1204-2     Document Type: Article

References (25)

1. Longstreth GF, Thompson WG, Chey WD et al (2006) Functional bowel disorders. Gastroenterology 130:1480–1491
2. Higgins PD, Johanson JF (2004) Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 99:441–449
3. Stewart WF, Liberman JN, Sandler RS et al (1999) Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 94:3530–3540
4. Wald A, Kamm M, Mueller-Lissner S et al (2006) The BI Omnibus study: an international survey of community prevalence of constipation and laxative use in adults. Gastroenterology 130:508
5. Dennison C, Prasad M, Lloyd A et al (2005) The health-related quality of life and economic burden of constipation. Pharmacoeconomics 23:461–476
6. Yost KJ, Haan MN, Levine RA et al (2005) Comparing SF-36 scores across three groups of women with different health profiles. Qual Life Res 14:1251–1261
7. Johanson JF (2007) Review of the treatment options for chronic constipation. Med Gen Med 9:25
8. Petticrew M, Rodgers M, Booth A (2001) Effectiveness of laxatives in adults. Qual Health Care 10:268–273
9. Jones MP, Talley NJ, Nuyts G et al (2002) Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci 47:2222–2230
10. Tramonte SM, Brand MB, Mulrow CD et al (1997) The treatment of chronic constipation in adults: a systematic review. J Gen Intern Med 12:15–24
11. Quigley EMM (2012) Prucalopride: safety, efficacy and potential applications. Ther Adv Gastroenterol 5:23–30
12. Camilleri M, Kerstens R, Rykx A (2008) A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 358:2344–2354
13. Tack J, van Outryve M, Beyens G et al (2009) Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 58:357–365
14. Quigley EMM, Vandeplassche L, Kerstens R et al (2008) Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation—a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 29:315–328
15. Tack J, Quigley E, Camilleri M et al (2013) Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis. UEG J 1:48–59
16. Mauskopf JA, Sullivan SD, Annemans L et al (2007) Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices—budget impact analysis. Value in Health 10:336–347
17. (2011) TA211 Prucalopride chronic constipation in women: costing template. Available at: http://guidance.nice.org.uk/TA211/CostingTemplate/xls/English. Accessed 14 May 2012
18. (2010) Constipation (women)—Prucalopride (TA211). Available at: http://guidance.nice.org.uk/TA211. Accessed 14 May 2012
19. Monthly Index of Medical Specialties Ireland (MIMS Ireland) (2012) MPI Media Ltd, Dublin, Ireland
20. Lynch J (2001) The health economic implications of treatment with quetiapine: an audit of long term treatment for patients with chronic schizophrenia. Eur Psychiatry 16(5):307–312
21. Rantis PC Jr, Vernava AM, Daniel GL et al (1997) Chronic constipation—is the work-up worth the cost? Dis Colon Rectum 40:280–286
22. Nyrop KA (2007) Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther 26(2):237–248
23. Lynch J (2001) The health economic implications of treatment with quetiapine: an audit of long term treatment for patients with chronic schizophrenia. Eur Psychiatry 16(5):307–312
24. Addison R (2003) A national audit of chronic constipation in the community. Nurs Times 99(11):34–35
25. Jones MP (2002) Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci 47(10):2222–2230